Tom Tiffany (R) claims he has not been restrictive on cannabis reform
Well, he certainly did not help!
Voter Guide: Rep. Tom Tiffany (R–WI) – Cannabis Policy Overview
Background
- Wisconsin State Assembly: Elected 2010
- Wisconsin State Senate: Elected 2012
- U.S. House of Representatives: Elected 2020 (WI-07)
Rep. Tom Tiffany has made cannabis policy part of several public interviews and votes over the years. The following sections summarize his positions and record.
Federal Record (2020–Present)
Votes Supporting Limited Cannabis Research
- Medical Marijuana Research Act:
Tiffany voted in favor of legislation to ease federal restrictions on scientific and medical cannabis research.
Votes Opposing Broader Federal Cannabis Reform
- MORE Act:
Voted against the Marijuana Opportunity Reinvestment and Expungement Act, which proposed descheduling cannabis at the federal level and providing record expungement mechanisms. - SAFE Banking Act:
Voted against allowing state-legal cannabis businesses access to banking and financial services.
These votes reflect support for expanding research while maintaining opposition to major legal or structural changes to federal cannabis policy.
Public Statements at the Federal Level
- Tiffany has stated in interviews that cannabis decisions should be handled at the state level rather than by Congress.
- He has emphasized the need for additional research on public health and safety impacts.
- In recent media appearances, he has described his stance as cautious rather than restrictive.
State-Level Context (2010–2020)
Legislative Environment
During Tiffany’s tenure in the Wisconsin Legislature, cannabis reform measures did not receive floor votes in either chamber. Republican leadership held majority control and did not advance decriminalization or medical cannabis bills to final consideration.
Tiffany’s Position During His State Service
- Tiffany did not sponsor or co-sponsor cannabis reform bills during his time in the Legislature.
- He publicly expressed opposition to decriminalization initiatives in committee hearings and media appearances.
- The 2019–2020 Republican medical marijuana proposal did not advance; Tiffany was not listed as a supporter or co-sponsor.
Although no final votes occurred, Tiffany’s public statements and alignment with caucus positions placed him on the side of maintaining existing prohibitions.
Recent Interviews and Statements
In recent discussions on DrydenWire and other platforms:
- Tiffany has reiterated support for additional research.
- He has described his federal role as avoiding national legalization while respecting state choices.
- These statements contrast with his prior public positions and voting history, which show consistent opposition to broad legalization measures.
Summary
Rep. Tom Tiffany’s record on cannabis policy shows:
- Support for expanded scientific research,
- Opposition to broad federal reform measures, and
- A history of public opposition to state-level decriminalization and legalization efforts during his time in Madison, despite no floor votes occurring.
This guide provides an overview for voters and constituents who wish to understand his work and statements related to cannabis policy.
